Heather-jane J. Au

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).

Palliative chemoradiotherapy versus radiotherapy alone for dysphagia in advanced oesophageal cancer: a multicentre randomised controlled trial (TROG 03.01).

Journal: The lancet. Gastroenterology & hepatology

Published: August 24, 2017

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.

Significance of baseline and change in quality of life scores in predicting clinical outcomes in an international phase III trial of advanced pancreatic cancer: NCIC CTG PA.3.

Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]

Published: July 07, 2016

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

Journal: Clinical breast cancer

Published: May 22, 2015

Feasibility and efficacy of a 12-week supervised exercise intervention for colorectal cancer survivors.

Feasibility and efficacy of a 12-week supervised exercise intervention for colorectal cancer survivors.

Journal: Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

Published: May 30, 2014

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.

A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: December 05, 2013

Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.

Quality of life in patients with K-RAS wild-type colorectal cancer: the CO.20 phase 3 randomized trial.

Journal: Cancer

Published: July 16, 2013

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.

Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study.

Journal: The oncologist

Published: July 02, 2013

Factors associated with delays to medical assessment and diagnosis for patients with colorectal cancer.

Factors associated with delays to medical assessment and diagnosis for patients with colorectal cancer.

Journal: Canadian family physician Medecin de famille canadien

Published: September 14, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026